Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Enzalutamide|DRUG: Fulvestrant
Sponsor: University of Colorado, Denver
Collaborators: United States Department of Defense